Institutional
Artia Global Partners LP
CIK 0001937964
$499.4M
Reported AUM
49
Positions
Q1 2026
Period
2026-05-15
Filed
The Brief · Artia Global Partners LP · Q1 2026
AI · grounded in 13F
Artia Global Partners LP exited its position in ProShares TR II UGL, reducing its exposure by $30.1M. The fund also closed its position in uniQure NV QURE for $24.5M. On the buy side, the fund established a new position in AstraZeneca PLC AZN worth $18.8M and added Moderna Inc MRNA with a $10.2M investment.
Portfolio · Q1 2026
Top holdings
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | INSM | INSMED INC | $101.49 | -1.58% | -7.34% | 259.18% | $148.5M | 29.74% | — | HELD |
| 2 | ABVX | ABIVAX SA | $124.33 | 4.62% | 72.81% | 1124.93% | $66.9M | 13.39% | — | HELD |
| 3 | LLY | ELI LILLY & CO | $1154.97 | -4.55% | 54.61% | 373.33% | $35.2M | 7.04% | — | HELD |
| 4 | TRVI | TREVI THERAPEUTICS INC | $18.40 | 1.71% | 145.09% | 982.23% | $24.0M | 4.81% | — | HELD |
| 5 | ARGX | ARGENX SE | $872.58 | -1.13% | 29.50% | 163.60% | $21.7M | 4.35% | — | HELD |
| 6 | AZN | ASTRAZENECA PLC | $171.34 | -1.13% | 17.87% | 62.01% | $18.8M | 3.77% | — | HELD |
| 7 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $28.46 | 1.97% | 33.74% | 194.62% | $16.1M | 3.23% | — | HELD |
| 8 | DNTH | DIANTHUS THERAPEUTICS INC | $112.64 | 8.21% | 447.06% | 10.00% | $13.7M | 2.74% | — | HELD |
| 9 | RVMD | REVOLUTION MEDICINES INC | $192.17 | 6.22% | 424.62% | 560.61% | $12.2M | 2.43% | — | HELD |
| 10 | IONS | IONIS PHARMACEUTICALS INC | $53.28 | -1.41% | 25.59% | 35.92% | $10.8M | 2.17% | — | HELD |
| 11 | MRNA | MODERNA INC | $57.92 | 6.29% | 109.82% | -84.62% | $10.2M | 2.03% | — | HELD |
| 12 | EYPT | EYEPOINT INC | $12.86 | 7.89% | 22.76% | 8.96% | $9.9M | 1.98% | — | HELD |
| 13 | DGX | QUEST DIAGNOSTICS INC | $234.30 | -0.39% | 39.63% | 69.06% | $8.0M | 1.60% | — | HELD |
| 14 | ALMS | ALUMIS INC | $28.95 | 9.74% | 563.92% | 122.93% | $7.2M | 1.43% | — | HELD |
| 15 | VKTX | VIKING THERAPEUTICS INC | $33.11 | -0.96% | 1.32% | 400.91% | $5.9M | 1.18% | — | HELD |
| 16 | MRK | MERCK & CO INC | $129.79 | -0.44% | 66.99% | 96.29% | $5.6M | 1.12% | — | HELD |
| 17 | 430 | TERNS PHARMACEUTICALS INC | — | — | — | — | $5.5M | 1.11% | — | HELD |
| 18 | JNJ | JOHNSON & JOHNSON | $255.82 | -3.66% | 56.99% | 69.37% | $5.5M | 1.11% | — | HELD |
| 19 | SION | SIONNA THERAPEUTICS INC | $46.78 | 4.40% | 170.45% | 337.48% | $4.8M | 0.96% | — | HELD |
| 20 | SRRK | SCHOLAR ROCK HLDG CORP | $48.99 | -0.14% | 34.93% | 24.11% | $4.7M | 0.95% | — | HELD |
| 21 | RAPP | RAPPORT THERAPEUTICS INC | $42.78 | 4.49% | 202.33% | 88.29% | $4.3M | 0.87% | — | HELD |
| 22 | ASNDUSD | ASCENDIS PHARMA A/S | — | — | — | — | $4.1M | 0.81% | — | HELD |
| 23 | BLTE | BELITE BIO INC | $159.92 | 4.91% | 135.39% | 923.15% | $4.0M | 0.80% | — | HELD |
| 24 | XENE | XENON PHARMACEUTICALS INC | $64.19 | 1.73% | 106.89% | 257.51% | $3.8M | 0.76% | — | HELD |
| 25 | MLYS | MINERALYS THERAPEUTICS INC | $26.19 | -0.61% | 90.49% | 66.22% | $3.7M | 0.75% | — | HELD |
| 26 | ROIV | ROIVANT SCIENCES LTD | $34.52 | 5.02% | 202.21% | 243.52% | $3.6M | 0.72% | — | HELD |
| 27 | PALI | PALISADE BIO INC | $1.96 | 0.00% | 95.05% | -99.91% | $3.5M | 0.70% | — | HELD |
| 28 | BIIB | BIOGEN INC | $207.93 | -0.62% | 55.75% | -39.36% | $3.4M | 0.68% | — | HELD |
| 29 | PROK | PROKIDNEY CORP | $1.58 | 2.60% | -45.39% | -84.21% | $3.2M | 0.65% | — | HELD |
| 30 | ABBV | ABBVIE INC | $257.41 | -2.24% | 36.96% | 157.96% | $3.2M | 0.63% | — | HELD |
| 31 | UTHR | UNITED THERAPEUTICS CORP DEL | $525.82 | 0.21% | — | — | $3.0M | 0.59% | — | HELD |
| 32 | DRUG | BRIGHT MINDS BIOSCIENCES INC | $74.63 | 5.02% | — | — | $2.8M | 0.56% | — | HELD |
| 33 | PTGX | PROTAGONIST THERAPEUTICS INC | $138.64 | 4.24% | — | — | $2.4M | 0.48% | — | HELD |
| 34 | SLNO | SOLENO THERAPEUTICS INC | — | — | — | — | $2.3M | 0.46% | — | HELD |
| 35 | BTSG | BRIGHTSPRING HEALTH SVCS INC | $72.88 | 5.06% | — | — | $2.3M | 0.46% | — | HELD |
| 36 | TVTX | TRAVERE THERAPEUTICS INC | $57.28 | 3.10% | — | — | $2.1M | 0.42% | — | HELD |
| 37 | EWTX | EDGEWISE THERAPEUTICS INC | $41.12 | 3.45% | — | — | $2.1M | 0.41% | — | HELD |
| 38 | CELC | CELCUITY INC | $87.64 | 5.26% | — | — | $1.8M | 0.36% | — | HELD |
| 39 | BBIO | BRIDGEBIO PHARMA INC | $82.14 | -1.68% | — | — | $1.5M | 0.30% | — | HELD |
| 40 | KNSA | KINIKSA PHARMACEUTICALS INTL | $78.20 | -3.36% | — | — | $1.4M | 0.28% | — | HELD |
| 41 | CYTK | CYTOKINETICS INC | $80.42 | 2.59% | — | — | $1.1M | 0.22% | — | HELD |
| 42 | ELVN | ENLIVEN THERAPEUTICS INC | $53.95 | 1.85% | — | — | $819K | 0.16% | — | HELD |
| 43 | PRAX | PRAXIS PRECISION MEDICINES I | $307.75 | 5.75% | — | — | $805K | 0.16% | — | HELD |
| 44 | TENX | TENAX THERAPEUTICS INC | $15.10 | 1.89% | — | — | $673K | 0.13% | — | HELD |
| 45 | KOD | KODIAK SCIENCES INC | $42.50 | 6.22% | — | — | $649K | 0.13% | — | HELD |
| 46 | NUVL | NUVALENT INC | — | — | — | — | $502K | 0.10% | — | HELD |
| 47 | APGE | APOGEE THERAPEUTICS INC | $134.30 | 0.07% | — | — | $495K | 0.10% | — | HELD |
| 48 | AVTX | AVALO THERAPEUTICS INC | $19.39 | 2.00% | — | — | $433K | 0.09% | — | HELD |
| 49 | PEPG | PEPGEN INC | $1.78 | 4.09% | — | — | $363K | 0.07% | — | HELD |
Source: SEC EDGAR · accession 0001937964-26-000007. 13F discloses long positions only — shorts, foreign equities, and options are excluded.